Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Kallikrein-14 (Homo sapiens (Human)) | BDBM113060 (US9695194, 1) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | Purchase MCE PC cid PC sid UniChem | US Patent | 100 | -41.6 | n/a | n/a | n/a | n/a | n/a | 8.0 | 37 |
SIXERA PHARMA AB US Patent | Assay Description Materials: Recombinant human KLK14, Substrate S-2302 (Chromogenics, cat. no. 820340). KLK14 activity was determined at 37° C. in 0.1 mM Tris, pH ... | US Patent US9695194 (2017) BindingDB Entry DOI: 10.7270/Q2CN723D | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Kallikrein-14 (Homo sapiens (Human)) | BDBM113065 (US9695194, 2) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | 100 | -41.6 | n/a | n/a | n/a | n/a | n/a | 8.0 | 37 |
SIXERA PHARMA AB US Patent | Assay Description Materials: Recombinant human KLK14, Substrate S-2302 (Chromogenics, cat. no. 820340). KLK14 activity was determined at 37° C. in 0.1 mM Tris, pH ... | US Patent US9695194 (2017) BindingDB Entry DOI: 10.7270/Q2CN723D | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Kallikrein-14 (Homo sapiens (Human)) | BDBM113069 (US9695194, 5) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | 300 | -38.7 | n/a | n/a | n/a | n/a | n/a | 8.0 | 37 |
SIXERA PHARMA AB US Patent | Assay Description Materials: Recombinant human KLK14, Substrate S-2302 (Chromogenics, cat. no. 820340). KLK14 activity was determined at 37° C. in 0.1 mM Tris, pH ... | US Patent US9695194 (2017) BindingDB Entry DOI: 10.7270/Q2CN723D | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Kallikrein-14 (Homo sapiens (Human)) | BDBM113067 (US9695194, 3) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | 500 | -37.4 | n/a | n/a | n/a | n/a | n/a | 8.0 | 37 |
SIXERA PHARMA AB US Patent | Assay Description Materials: Recombinant human KLK14, Substrate S-2302 (Chromogenics, cat. no. 820340). KLK14 activity was determined at 37° C. in 0.1 mM Tris, pH ... | US Patent US9695194 (2017) BindingDB Entry DOI: 10.7270/Q2CN723D | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Kallikrein-14 (Homo sapiens (Human)) | BDBM113299 (US9695194, 15) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 500 | -37.4 | n/a | n/a | n/a | n/a | n/a | 8.0 | 37 |
SIXERA PHARMA AB US Patent | Assay Description Materials: Recombinant human KLK14, Substrate S-2302 (Chromogenics, cat. no. 820340). KLK14 activity was determined at 37° C. in 0.1 mM Tris, pH ... | US Patent US9695194 (2017) BindingDB Entry DOI: 10.7270/Q2CN723D | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Kallikrein-14 (Homo sapiens (Human)) | BDBM113296 (US9695194, 13) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | 800 | -36.2 | n/a | n/a | n/a | n/a | n/a | 8.0 | 37 |
SIXERA PHARMA AB US Patent | Assay Description Materials: Recombinant human KLK14, Substrate S-2302 (Chromogenics, cat. no. 820340). KLK14 activity was determined at 37° C. in 0.1 mM Tris, pH ... | US Patent US9695194 (2017) BindingDB Entry DOI: 10.7270/Q2CN723D | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Kallikrein-14 (Homo sapiens (Human)) | BDBM113068 (US9695194, 4) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | 1.00E+3 | -35.6 | n/a | n/a | n/a | n/a | n/a | 8.0 | 37 |
SIXERA PHARMA AB US Patent | Assay Description Materials: Recombinant human KLK14, Substrate S-2302 (Chromogenics, cat. no. 820340). KLK14 activity was determined at 37° C. in 0.1 mM Tris, pH ... | US Patent US9695194 (2017) BindingDB Entry DOI: 10.7270/Q2CN723D | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Kallikrein-14 (Homo sapiens (Human)) | BDBM113301 (US9695194, 17) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | 1.10E+3 | -35.4 | n/a | n/a | n/a | n/a | n/a | 8.0 | 37 |
SIXERA PHARMA AB US Patent | Assay Description Materials: Recombinant human KLK14, Substrate S-2302 (Chromogenics, cat. no. 820340). KLK14 activity was determined at 37° C. in 0.1 mM Tris, pH ... | US Patent US9695194 (2017) BindingDB Entry DOI: 10.7270/Q2CN723D | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Kallikrein-14 (Homo sapiens (Human)) | BDBM113295 (US9695194, 12) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | 1.10E+3 | -35.4 | n/a | n/a | n/a | n/a | n/a | 8.0 | 37 |
SIXERA PHARMA AB US Patent | Assay Description Materials: Recombinant human KLK14, Substrate S-2302 (Chromogenics, cat. no. 820340). KLK14 activity was determined at 37° C. in 0.1 mM Tris, pH ... | US Patent US9695194 (2017) BindingDB Entry DOI: 10.7270/Q2CN723D | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Kallikrein-14 (Homo sapiens (Human)) | BDBM113300 (US9695194, 16) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | 1.30E+3 | -34.9 | n/a | n/a | n/a | n/a | n/a | 8.0 | 37 |
SIXERA PHARMA AB US Patent | Assay Description Materials: Recombinant human KLK14, Substrate S-2302 (Chromogenics, cat. no. 820340). KLK14 activity was determined at 37° C. in 0.1 mM Tris, pH ... | US Patent US9695194 (2017) BindingDB Entry DOI: 10.7270/Q2CN723D | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Kallikrein-14 (Homo sapiens (Human)) | BDBM113119 (US9695194, 6) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | 1.40E+3 | -34.8 | n/a | n/a | n/a | n/a | n/a | 8.0 | 37 |
SIXERA PHARMA AB US Patent | Assay Description Materials: Recombinant human KLK14, Substrate S-2302 (Chromogenics, cat. no. 820340). KLK14 activity was determined at 37° C. in 0.1 mM Tris, pH ... | US Patent US9695194 (2017) BindingDB Entry DOI: 10.7270/Q2CN723D | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Kallikrein-14 (Homo sapiens (Human)) | BDBM113297 (US9695194, 14) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | 1.50E+3 | -34.6 | n/a | n/a | n/a | n/a | n/a | 8.0 | 37 |
SIXERA PHARMA AB US Patent | Assay Description Materials: Recombinant human KLK14, Substrate S-2302 (Chromogenics, cat. no. 820340). KLK14 activity was determined at 37° C. in 0.1 mM Tris, pH ... | US Patent US9695194 (2017) BindingDB Entry DOI: 10.7270/Q2CN723D | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Kallikrein-14 (Homo sapiens (Human)) | BDBM113292 (US9695194, 9) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | 1.50E+3 | -34.6 | n/a | n/a | n/a | n/a | n/a | 8.0 | 37 |
SIXERA PHARMA AB US Patent | Assay Description Materials: Recombinant human KLK14, Substrate S-2302 (Chromogenics, cat. no. 820340). KLK14 activity was determined at 37° C. in 0.1 mM Tris, pH ... | US Patent US9695194 (2017) BindingDB Entry DOI: 10.7270/Q2CN723D | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Kallikrein-14 (Homo sapiens (Human)) | BDBM50289001 (2-(2-Iodo-phenyl)-6,7-dimethoxy-benzo[d][1,3]oxazi...) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | Purchase CHEMBL PC cid PC sid UniChem Similars | US Patent | 2.10E+3 | -33.7 | n/a | n/a | n/a | n/a | n/a | 8.0 | 37 |
SIXERA PHARMA AB US Patent | Assay Description Materials: Recombinant human KLK14, Substrate S-2302 (Chromogenics, cat. no. 820340). KLK14 activity was determined at 37° C. in 0.1 mM Tris, pH ... | US Patent US9695194 (2017) BindingDB Entry DOI: 10.7270/Q2CN723D | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Kallikrein-14 (Homo sapiens (Human)) | BDBM113283 (US9695194, 8) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | 2.30E+3 | -33.5 | n/a | n/a | n/a | n/a | n/a | 8.0 | 37 |
SIXERA PHARMA AB US Patent | Assay Description Materials: Recombinant human KLK14, Substrate S-2302 (Chromogenics, cat. no. 820340). KLK14 activity was determined at 37° C. in 0.1 mM Tris, pH ... | US Patent US9695194 (2017) BindingDB Entry DOI: 10.7270/Q2CN723D | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Kallikrein-14 (Homo sapiens (Human)) | BDBM113248 (US9695194, 7) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | 2.70E+3 | -33.1 | n/a | n/a | n/a | n/a | n/a | 8.0 | 37 |
SIXERA PHARMA AB US Patent | Assay Description Materials: Recombinant human KLK14, Substrate S-2302 (Chromogenics, cat. no. 820340). KLK14 activity was determined at 37° C. in 0.1 mM Tris, pH ... | US Patent US9695194 (2017) BindingDB Entry DOI: 10.7270/Q2CN723D | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Kallikrein-14 (Homo sapiens (Human)) | BDBM113293 (US9695194, 10) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | 5.20E+3 | -31.4 | n/a | n/a | n/a | n/a | n/a | 8.0 | 37 |
SIXERA PHARMA AB US Patent | Assay Description Materials: Recombinant human KLK14, Substrate S-2302 (Chromogenics, cat. no. 820340). KLK14 activity was determined at 37° C. in 0.1 mM Tris, pH ... | US Patent US9695194 (2017) BindingDB Entry DOI: 10.7270/Q2CN723D | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Kallikrein-14 (Homo sapiens (Human)) | BDBM113294 (US9695194, 11) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | >1.00E+4 | >-29.7 | n/a | n/a | n/a | n/a | n/a | 8.0 | 37 |
SIXERA PHARMA AB US Patent | Assay Description Materials: Recombinant human KLK14, Substrate S-2302 (Chromogenics, cat. no. 820340). KLK14 activity was determined at 37° C. in 0.1 mM Tris, pH ... | US Patent US9695194 (2017) BindingDB Entry DOI: 10.7270/Q2CN723D | |||||||||||
More data for this Ligand-Target Pair |